EDITAS MEDICINE INC (EDIT) Stock Income Statement
NASDAQ:EDIT - Nasdaq - US28106W1036 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 35.84M | 32.31M | 78.12M | 19.71M | 25.54M | |||
| Operating Expenses | 243.08M | 271.23M | 247.30M | 245.66M | 218.69M | |||
| Research and Development | 177.05M | 199.25M | 177.65M | 174.96M | 142.51M | |||
| Selling, General, and Administrative Expenses | 66.02M | 71.99M | 69.65M | 70.70M | 76.18M | |||
| Operating Income | -207.24M | -238.92M | -169.18M | -225.95M | -193.15M | |||
| Interest Income/Expense | 9.53M | 14.06M | 17.57M | 4.23M | 2.34M | |||
| Other Income/Expense | -434.00K | -3.00K | -1.60M | 1.29M | -1.70M | |||
| Non Recurring Items | N/A | -12.23M | N/A | N/A | N/A | |||
| Income Before Taxes | -251.23M | -237.09M | -153.22M | -220.43M | -192.50M | |||
| Income Tax | N/A | 0.00 | N/A | N/A | N/A | |||
| Net Income | -251.23M | -237.09M | -153.22M | -220.43M | -192.50M | |||
| EBITDA | -200.92M | -233.11M | -163.12M | -219.61M | -188.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.04 | -2.88 | -2.02 | -3.21 | -2.85 | |||
| Non GAAP EPS | -3.04 | -2.88 | -2.05 | -3.21 | -2.85 | |||
| Statistics | ||||||||
| Profit Margin | -701.06% | -733.72% | -196.13% | -1118.37% | -753.72% | |||
| Operating Profit Margin | -578.30% | -739.37% | -216.56% | -1146.37% | -756.26% | |||
All data in USD